Oncology News | pharmaphorum

News

A false color scanning election micrograph of lung cancer cells grown in culture

Experimental AI predicts whether cancer drugs will work

Researchers in the US have developed an artificial intelligence tool that can predict how a patient will respond to cancer treatment, bringing the concept of personalised

News

FDA clears Roche’s Alecensa for adjuvant use in NSCLC

Roche has broken new ground with its ALK inhibitor Alecenesa, becoming the first drug in the class to be approved by the FDA for adjuvant use after surgery in early-stage,

News

Boehringer says R&D pipeline is the best in its long history

Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that

News

‘Stiffness’ of cells could give early warning of cancer

A new technology developed in the UK could make it possible to detect cancer at an early stage, long before the formation of a lump, by investigating the stiffness of indi

News

After ph3 win, Roche eyes earlier use of Columvi in DLBCL

Roche’s CD20xCD3 bispecific antibody Columvi has improved survival when used as a second-line therapy for diffuse large B-cell lymphoma (DLBCL) in a phase 3 trial, setting

News

Novartis adds clinical-stage protein degrader from Arvinas

Novartis has accelerated its efforts to develop protein degrader therapies by licensing a prostate cancer candidate from Arvinas on the brink of starting phase 3 trials in

Experimental AI predicts whether cancer drugs will work

FDA clears Roche’s Alecensa for adjuvant use in NSCLC

Boehringer says R&D pipeline is the best in its long history

‘Stiffness’ of cells could give early warning of cancer

After ph3 win, Roche eyes earlier use of Columvi in DLBCL

Novartis adds clinical-stage protein degrader from Arvinas

On genomics, NGS, and doing much more good than bad, with Ma...

How to meet your physicians where they are online

News

Editor's Picks